{"database": "openregs", "table": "dockets", "rows": [["FDA-2003-P-0015", "FDA", "Make A Determination that the Galderma Product, Solage Containing 2% Mequinol, and 0.01% Tretinoin, NDA 20-922 Can Be Formulated As A Topical Solution with the Substitution of Hydroquinone at 4% for the 2% Mequinol and Fled as an ANDA Referencing Solage, NDA 20-922 as the Reference Listed Drug-CLOSED", "Nonrulemaking", "2021-09-01T01:02:53Z", "0b00006480481323"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2003-P-0015"], "units": {}, "query_ms": 0.7726838812232018, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}